We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    NCT01971671
Previous Study | Return to List | Next Study

Evaluation of the Nutrients Composition of Breast Milk of Chinese Lactating Mothers and Their Nutrition Intake (MING)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01971671
Recruitment Status : Completed
First Posted : October 29, 2013
Last Update Posted : October 29, 2013
Sponsor:
Information provided by (Responsible Party):
Société des Produits Nestlé (SPN)

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
To understand breast milk composition during different lactating stages.

Condition or disease Intervention/treatment
Focus of Study is Healthy Chinese Lactating Mother 0-270 Days Other: no intervention.

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 560 participants
Time Perspective: Cross-Sectional
Official Title: Evaluation of the Nutrients Composition of Breast Milk of Chinese Lactating Mothers and Nutrition Intake of Chinese Pregnant and Lactating Mothers, Infants and Young Children
Study Start Date : August 2011
Actual Primary Completion Date : January 2012
Actual Study Completion Date : January 2012
Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Chinese lactating mother
no intervention.
 Other: no intervention.


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Primary outcome is the macronutrient composition of breast milk in Chinese lactating mothers from 0 to 270 days after delivery. [ Time Frame: 0-270 days after delivery ]
    Macronutrient composition includes calories (kcal/ml), total protein, fat and carbohydrate (lactose) content in breast milk.


Secondary Outcome Measures :
  1. Other nutrient composition in breast milk of 0-270 days after delivery. [ Time Frame: 0-270 days after delivery. ]
    Beside macronutrient composition, all major minerals, vitamins will be analyzed. In addition, functional compounds, such as human milk oligosaccharides (HMOs), total/free amino acids, lipid profiles, and microbiota, will be analyzed as well.

  2. Dietary pattern of lactating mothers of 0-270 days after delivery. [ Time Frame: 0-270 days after delivery. ]
    A one-time standardized 24-hour food recall survey, is utilized to access dietary pattern of subjects.

  3. Nutrients intake and adequacy of lactating mothers of 0-270 days after delivery. [ Time Frame: 0-270 days after delivery ]
    A one-time standardized 24-hour food recall survey, is utilized to access nutrient intakes and adequacy (by comparing existing local and international RDAs and DRIs databases).

  4. Nutrition supplements intake status of lactating mothers of 0-270 days after delivery. [ Time Frame: 0-270 days after delivery. ]
    A one-time food frequency questionnaire (FFQ), designed to access nutritional supplement usage, is being utilized.


Biospecimen Retention:   Samples Without DNA
breask milk sample.

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
Healthy Chinese lactating mother 0-270 days after delivery (inclusive) will be enrolled.
Criteria

Inclusion Criteria:

  • Chinese lactating mother 0-270 days after delivery (inclusive).
  • Healthy with neither acute disease nor history of hereditary disease, gestational diabetes, hypertension, other concomitant diseases, and disability.
  • Parents/ caregiver is willing to comply with the study procedure.
  • Having received oral and written information about the aims and procedures of the study.
  • Having obtained the her informed consent.

Exclusion Criteria:

  • Subjects who are currently taking, or have taken in the last 4 weeks, or will take any medication.
  • Subject who has history of psychopath and have no the dietary memory.
  • Subjects who are suffering food allergy.
  • Insufficient breast milk output according to the corresponding period after delivery.
  • Alcoholic.
  • Smokers.
  • Subject who cannot be expected to comply with the study procedures.
  • Currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study.
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01971671


Locations
Layout table for location information
China, Beijing
Health Science Center, Peking University
Beijing, Beijing, China, 100191
Sponsors and Collaborators
Société des Produits Nestlé (SPN)
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Société des Produits Nestlé (SPN)
ClinicalTrials.gov Identifier: NCT01971671    
Other Study ID Numbers: 11.14.NRC
First Posted: October 29, 2013    Key Record Dates
Last Update Posted: October 29, 2013
Last Verified: October 2013